Complera (Rilpivirine/Tenofovir/FTC)
| Brand Name: |
Complera |
| Generic Name: |
Rilpivirine/tenofovir/
FTC |
| Adult Single Dose: |
One tablet (containing 200 mg of emtricitabine, 25 mg of rilpivirine, and 300 mg of tenofovir disoproxil fumarate) taken once daily |
| Food & Liquid Restrictions: |
Take with meal |
| Drug Class: |
1 NNRTI + 2 NRTIs |
|
|
|
The Basics
News & Research
- Complera Labeling Update: No Longer Recommended at High Viral Loads; Hepatotoxicity Precaution Added (January 28, 2013)
From U.S. Food and Drug Administration
On TheBodyPRO.com
- HIV Drug Updates (September/October 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
On TheBodyPRO.com
- Switching From Protease Inhibitor to Complera Maintains Viral Suppression, Lowers Lipids (August 3, 2012)
From HIVandHepatitis.com
- The Path to a Cure (January/February 2012)
The pathway to an HIV cure and other treatments in the pipeline.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Switching From Atripla to Complera (January/February 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Complera and Atripla News (January/February 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
 Top 10 HIV/AIDS-Related Clinical Developments of 2011 (December 1, 2011)
David Alain Wohl, M.D., on HIV treatment as prevention; the dawning of pre-exposure prophylaxis (PrEP), but with women absent; the concept of "viremia copy-years"; the impact of race and gender on HIV treatment outcomes; setbacks for two treatment approaches involving Isentress; new hepatitis C therapies; a new once-daily HIV pill; the rising rates of HIV among black MSM; and what comes after "test and treat."
From TheBody.com
 Complera, My New 1-Pill-a-Day Regimen (and My Rosacea Diagnosis): A Video Blog Entry by Justin B. Terry-Smith (October 19, 2011)
"I started Complera about 1 week ago ... I haven't had any bad things or side effects yet. ... I'm very happy about this one-pill-a-day regimen. ... But I am the producer for an event which at times can be stressful around the same time of year. Because of this stress I've been diagnosed with rosacea."
From TheBody.com
- FDA Approve New NNRTI-Based Fixed-Dose Combination of Rilpivirine/Tenofovir/FTC (Complera) in the U.S. (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- FDA Approves the New Full-Regimen HIV Pill Complera (August 12, 2011)
From Project Inform
- U.S. Food and Drug Administration Approves Gilead's Once-Daily HIV Pill Complera (August 11, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
 FDA Approves Complera (Edurant + Truvada), a Second "All-in-One" Option for First-Line HIV Treatment (August 10, 2011)
From TheBody.com
 B-Tripla and a Bluey on Bondi Beach: A Blog Entry by Bob Frascino, M.D. (April 7, 2011)
"[Bronzed Aussie Surfer Dude:] It's been like a century since we've had a new HIV drug. What's up with that? Dr. Bob: Well, in reality it's been three years since the last new antiretrovirals hit the market. But I agree three years is a bit of a dry spell. The good news is that a new NNRTI is on its way to pharmacy shelves very soon."
From TheBody.com
|
Advertisement
|
Email
Glossary
